Category Archives: MS Treatment

Treatment for Severe Spasticity from MS Three people living with multiple sclerosis (MS) share their experiences with treatment for severe spasticity with an intrathecal baclofen pump (ITB Therapy). Multiple sclerosis can cause tight, stiff muscles or muscle spasms that make life difficult at work, school, or home. While severe spasticity can't be cured, it's important to know that treatments can help. Learn about one FDA-approved treatment option, the baclofen pump, at http://www.spasticity.com Intrathecal baclofen is not for everyone. Not everyone will receive the same results as the individuals shown in the video. Talk with your doctor to understand the benefits and risks of intrathecal baclofen therapy and to determine if it may be right for you. For important safety information, please visit http://www.spasticity.com A prescription is required. This video contains information about therapies approved for use in the United States and is intended to be viewed by residents of the United States.From:MDTSevereSpasticityViews:102 0ratingsTime:23:59More inScience Technology Read the original: Treatment for Severe Spasticity from MS - Video … Continue reading →

Multiple Sclerosis Chicago http://www.arlingtonheightsbbt.com. Natural MS treatment, affordableFrom:1163johnViews:45 0ratingsTime:00:31More inEducation See the original post: Multiple Sclerosis Chicago - Video … Continue reading →

Low Cholesterol and Multiple Sclerosis wwww.AskTheDoctor-MS.com. Low cholesterol is problematic for people with multiple sclerosis. Get a Total Cholesterol Test from your doctor and get your cholesterol levels tested. Cholesterol levels should be around 180. Learn more at http://www.GetSonicCholesterol.com to learn about cholesterol therapies. For more information about multiple sclerosis treatment, visit httpFrom:Brian WoellerViews:9 0ratingsTime:01:31More inScience Technology Go here to read the rest: Low Cholesterol and Multiple Sclerosis - Video … Continue reading →

Personalizing MS Treatment Imagine that your doctor could use your unique genetic profile and medical history to help make treatment decisions when you are sick. Dr. Philip De Jager and Dr. Elizabeth Karlson want to use the wealth of information on more than four million patients in the Partners HealthCare electronic health record system to help predict how people will respond to medicines used to treat diseases with symptom flare-ups, such as multiple sclerosis (MS). Dr. DeJager and Karlson are finalists for the 2012 BRIght Futures Prize. The $100000 prize is sponsored by the BWH Biomedical Research Institute.From:BrighamandwomensViews:53 0ratingsTime:03:08More inNonprofits Activism See original here: Personalizing MS Treatment - Video … Continue reading →

ms treatment http://www.ccsvi.mx - Medical tourism in Mexico has really grown in recent years and CCSVI treatment here has even attracted MS patients from all over the world to get affordable and high standard treatment!From:kristof stevenViews:10 0ratingsTime:01:12More inPeople Blogs View original post here: ms treatment - Video … Continue reading →

ccsvi treatment http://www.ccsvi.mx - Talking about ms treatment and the medical advancement and developing CCSVI, it is important to discuss in detail about the diseases, its symptoms and all the details about ccsvi treatment.From:kristof stevenViews:12 0ratingsTime:01:20More inPeople Blogs See the original post: ccsvi treatment - Video … Continue reading →

Hope for Lee Fundraising for ms treatmentFrom:lchuckryViews:6 1ratingsTime:11:23More inNonprofits Activism See the original post here: Hope for Lee - Video … Continue reading →

Oct. 27, 2012, 4:08 a.m. Shellharbour MP Anna Watson has called on the NSW government to consider a centre for eating disorders in the Illawarra. Ms Watson said she was moved by the experience of 15-year-old Chloe Swinfield, who went public about her three-year battle with anorexia to raise awareness about the loneliness she feels. Chloe, a patient at Westmead Hospital, often feels isolated from her support network and in her darkest hours wants to give up. MORE: Somebody help me, begs Chloe MORE: An open letter to Chloe Swinfield Her desperate mum, Jan Whitton, is struggling financially and with no car the trips to Sydney are taking their toll. Ms Watson urged NSW Minister for Mental Health Kevin Humphries to consider Chloe's plight and improve services in the Illawarra. "I would appreciate your consideration of ... whether it is possible to establish appropriate treatment services for anorexia and other eating disorders in the Illawarra, including the establishment of a centre for eating disorders within the region," Ms Watson said in a letter to the minister this week. Ms Whitton said she was frustrated her daughter was not treated as "someone with a real disease". Read the rest here: MP … Continue reading →

Data reinforces broad therapeutic potential of oral ADX71441 Program on track for CTA filing before end of 2012 Geneva, Switzerland, 29 October 2012 - (ADXN.SW), a leading company pioneering allosteric modulation-based drug discovery and development, announced today positive preclinical data for its GABA-B receptor positive allosteric modulator (PAM) oral small molecule, ADX71441, in a validated rodent model of alcohol binge drinking. ADX71441 demonstrated robust, dose-dependent and long-lasting suppression of alcohol intake in animals compared to naltrexone, the most-commonly prescribed treatment of alcoholism on the market. "These data are extremely encouraging and superior to naltrexone in our pre-clinical model, and warrant further exploration as a novel treatment for alcoholism," said Professor Klaus Miczek at Tufts University (USA) in whose laboratory the study was performed. Both clinical and pre-clinical data suggest that activation of the GABA-B receptor offers a unique therapeutic opportunity to address largely unmet needs of patients with alcohol and drug abuse by (1) reducing the alcohol or drug intake; (2) alleviating many physical signs (pain, Gastrointestinal/urinary disturbances) and emotional symptoms (anxiety) associated with withdrawal; and (3) maintaining abstinence by reducing alcohol or drug craving. ADX71441, which has potential for once daily dosing and selectively activates the GABA-B receptor, was … Continue reading →

NEW YORK (AP) Shares of Biogen Idec Inc. continued to slump Friday after the company said the Food and Drug Administration has delayed a decision on its multiple sclerosis pill BG-12. THE SPARK: On Thursday, Biogen said the FDA had extended its review of BG-12 by three months, which means the agency will make a ruling on the drug at the end of March 2013 instead of by the end of 2012. The Weston, Mass., company said the agency needed additional time to review the data it had submitted and was not asking Biogen to run additional clinical studies of BG-12. Friday was also a down day in the broader markets, as the Standard & Poor's 500 index fell 1.7 percent in afternoon trading. THE BIG PICTURE: Biogen filed for marketing approval of BG-12 early this year, and analysts think the drug will eventually bring the company billions of dollars in annual sales because it could become a leading option in treating multiple sclerosis. In clinical trials, Biogen said patients who took BG-12 were far less likely to have a relapse in symptoms than patients who took a placebo. The drug also worked better than Copaxone, an injection that is … Continue reading →